Webinar: Computational Protocols for in silico Target Validation
Edgar Jacoby (Janssen) discusses computational protocols for in silico target validation, and “knowing the knowns” in phenotypic screening. Watch webinar video | View webinar slides
Webinar: Target Validation Protocols
Now that the Open PHACTS project is complete, we’re opening our regular discussions about using Open PHACTS for science up to the whole community, with a series of free monthly webinars. Our next webinar will be about how the Open PHACTS Discovery Platform can be used for in silico target validation….
Conference: 251st ACS National Meeting & Exposition
251st ACS National Meeting & Exposition, San Diego, USA Herman van Vlijmen (Janssen) gave a presentation: Open PHACTS: Semantic interoperability for drug discovery Valery Tkachenko (Royal Society of Chemistry) gave a presentation: Implementing chemistry platform for Open PHACTS: Lessons learned Anna Gaulton (EMBL-EBI) gave a presentation: Representation of drug discovery knowledge in the…
Presentation: Open PHACTS: Semantic interoperability for drug discovery
251st ACS National Meeting & Exposition, San Diego, USA Herman van Vlijmen (Janssen) View presentation
Conference: 15th Annual Advances and Progress in Drug Design Conference 2016
15th Annual Advances and Progress in Drug Design Conference, London, UK Herman van Vlijmen (Janssen) gave a presentation: Linked open data in drug discovery: Where are we?
Presentation: Linked open data in drug discovery: Where are we?
Advances and Progress in Drug Design, London, UK Herman van Vlijmen (Janssen) View presentation
Conference: PiLOD Meeting
PiLOD Meeting, Hilversum, the Netherlands Herman van Vlijmen (Janssen) and Orri Erling (OpenLink Software) gave a presentation: Open PHACTS: Linked Open Data for Drug Discovery
Presentation: Open PHACTS: Linked Open Data for Drug Discovery
PiLOD Meeting, Hilversum, the Netherlands Herman van Vlijmen (Janssen), Orri Erling (OpenLink Software) View presentation
Press Release: Open PHACTS Foundation announces first three members: GSK, Janssen and Roche
(PDF) Cambridge, UK – The not-for-profit Open PHACTS Foundation announced its first three members today – GlaxoSmithKline, Janssen and Roche – who will steer the future of the successor organisation to the Innovative Medicines Initiative (IMI)- funded Open PHACTS project. The commitment by these global pharmaceutical industry members signifies a major…
2nd Open PHACTS Pipeline Pilot Hackathon held
On 6 March, 2014, the 2nd Open PHACTS Pipeline Pilot Hackathon took place on the Merck campus in Darmstadt, Germany. Attendees from eight different industrial and academic institutions worked on the new version 2.0 of the Open PHACTS component collection which was provided by Accelrys through financial support by Janssen Pharmaceutica….
Press Release: Five new partners join Open PHACTS
(PDF) The Open PHACTS consortium is pleased to announce that ConnectedDiscovery, the European Bioinformatics Institute, Janssen, the Netherlands Bioinformatics Centre, and the Swiss Institute of Bioinformatics have joined the project as new consortium members. The addition of these partners – bringing together respected drug discovery and bioinformatics expertise from academic institutions,…
Second Open PHACTS Workshop held
On 16-17 April 2012 the 2nd Open PHACTS Community Workshop was held at the RSC‘s Chemistry Centre, Burlington House, London. This workshop provided an understanding of the scientific and technical background to Open PHACTS, featured the current status, and gave the opportunity to discuss particular issues around data integration, licensing and…